- ALT +2.08%
Altimmune, Inc. (ALT): Why Are Hedge Funds Shorting This Biopharmaceutical Stock?
Yahoo Finance · 23 minutes ago
Open | 6.33 |
High | 6.90 |
Low | 6.06 |
Mkt Cap | 452.71M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 6.26 |
52 Wk. Low | 2.09 |
52 Wk. High | 14.84 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 5k | 76.20% ▼ |
Net Income | -24.39M | - |
Diluted EPS | -0.34 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.34 | - |
Q1 2024 | -$0.37 | -$0.34 |
Q4 2023 | -$0.43 | -$0.54 |
S&P FuturesES=F | 5,560.25+14.25 (+0.26%) |
Dow FuturesYM=F | 39,557.00+7.00 (+0.02%) |
Nasdaq FuturesNQ=F | 20,118.75+79.25 (+0.40%) |
NIKE, Inc.NKE | 94.19+0.14% |
12.19-22.16% | |
Chewy, Inc.CHWY | 29.05-0.31% |